Endoscopic Ultrasound-Guided Ablation of Liver Tumors

Tiffany Chua; Douglas O. Faigel

doi:10.1016/j.giec.2018.11.007

Endoscopic Ultrasound-Guided Ablation of Liver Tumors

Tiffany Chua, Douglas O. Faigel

Gastroenterology and Hepatology

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

“Endoscopic ultrasound (EUS)-guided ablative therapies have advanced significantly and have led to experimental applications in locations that have been difficult to image and/or reach with percutaneous approaches, such as the caudate and left lobe of the liver. EUS-guided treatments of the liver are under development. The literature has shown that many percutaneous ablative techniques are readily adaptable for EUS. In this review, the authors discuss the current developments on EUS-guided ablation of liver tumors, including injection of sclerosants, thermal therapy, and EUS-guided portal injection of chemotherapy.”

Original language	English (US)
Pages (from-to)	369-379
Number of pages	11
Journal	Gastrointestinal Endoscopy Clinics of North America
Volume	29
Issue number	2
DOIs	https://doi.org/10.1016/j.giec.2018.11.007
State	Published - Apr 2019

Keywords

EUS-guided ablation
EUS-guided fine needle injection (EUS-FNI)
EUS-guided portal injection chemotherapy (EPIC)
Hepatic metastases
Hepatocellular carcinoma
High-intensity focused ultrasound (HIFU)
Irreversible electroporation (IRE)
Radiofrequency ablation (RFA)

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1016/j.giec.2018.11.007

Cite this

@article{43d062cff6e04d0881d1449618484345,

title = "Endoscopic Ultrasound-Guided Ablation of Liver Tumors",

abstract = "“Endoscopic ultrasound (EUS)-guided ablative therapies have advanced significantly and have led to experimental applications in locations that have been difficult to image and/or reach with percutaneous approaches, such as the caudate and left lobe of the liver. EUS-guided treatments of the liver are under development. The literature has shown that many percutaneous ablative techniques are readily adaptable for EUS. In this review, the authors discuss the current developments on EUS-guided ablation of liver tumors, including injection of sclerosants, thermal therapy, and EUS-guided portal injection of chemotherapy.”",

keywords = "EUS-guided ablation, EUS-guided fine needle injection (EUS-FNI), EUS-guided portal injection chemotherapy (EPIC), Hepatic metastases, Hepatocellular carcinoma, High-intensity focused ultrasound (HIFU), Irreversible electroporation (IRE), Radiofrequency ablation (RFA)",

author = "Tiffany Chua and Faigel, {Douglas O.}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = apr,

doi = "10.1016/j.giec.2018.11.007",

language = "English (US)",

volume = "29",

pages = "369--379",

journal = "Gastrointestinal Endoscopy Clinics of North America",

issn = "1052-5157",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Endoscopic Ultrasound-Guided Ablation of Liver Tumors

AU - Chua, Tiffany

AU - Faigel, Douglas O.

PY - 2019/4

Y1 - 2019/4

N2 - “Endoscopic ultrasound (EUS)-guided ablative therapies have advanced significantly and have led to experimental applications in locations that have been difficult to image and/or reach with percutaneous approaches, such as the caudate and left lobe of the liver. EUS-guided treatments of the liver are under development. The literature has shown that many percutaneous ablative techniques are readily adaptable for EUS. In this review, the authors discuss the current developments on EUS-guided ablation of liver tumors, including injection of sclerosants, thermal therapy, and EUS-guided portal injection of chemotherapy.”

AB - “Endoscopic ultrasound (EUS)-guided ablative therapies have advanced significantly and have led to experimental applications in locations that have been difficult to image and/or reach with percutaneous approaches, such as the caudate and left lobe of the liver. EUS-guided treatments of the liver are under development. The literature has shown that many percutaneous ablative techniques are readily adaptable for EUS. In this review, the authors discuss the current developments on EUS-guided ablation of liver tumors, including injection of sclerosants, thermal therapy, and EUS-guided portal injection of chemotherapy.”

KW - EUS-guided ablation

KW - EUS-guided fine needle injection (EUS-FNI)

KW - EUS-guided portal injection chemotherapy (EPIC)

KW - Hepatic metastases

KW - Hepatocellular carcinoma

KW - High-intensity focused ultrasound (HIFU)

KW - Irreversible electroporation (IRE)

KW - Radiofrequency ablation (RFA)

UR - http://www.scopus.com/inward/record.url?scp=85060865255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060865255&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2018.11.007

DO - 10.1016/j.giec.2018.11.007

M3 - Review article

C2 - 30846159

AN - SCOPUS:85060865255

SN - 1052-5157

VL - 29

SP - 369

EP - 379

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

IS - 2

ER -

Endoscopic Ultrasound-Guided Ablation of Liver Tumors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this